Lymphoma, Extranodal NK-T-Cell
"Lymphoma, Extranodal NK-T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An extranodal neoplasm, usually possessing an NK-cell phenotype and associated with EPSTEIN-BARR VIRUS. These lymphomas exhibit a broad morphologic spectrum, frequent necrosis, angioinvasion, and most commonly present in the midfacial region, but also in other extranodal sites.
Concept/Terms
Lymphoma, Extranodal NK-T-Cell- Lymphoma, Extranodal NK-T-Cell
- Extranodal NK-T-Cell Lymphomas
- Lymphoma, Extranodal NK T Cell
- Lymphomas, Extranodal NK-T-Cell
- NK-T-Cell Lymphoma, Extranodal
- NK-T-Cell Lymphomas, Extranodal
- Extranodal NK-T-Cell Lymphoma
- Extranodal NK T Cell Lymphoma
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type- Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
- Extranodal NK T Cell Lymphoma, Nasal and Nasal Type
- Extranodal NK-T-Cell Lymphoma, Nasal Type
- Extranodal NK T Cell Lymphoma, Nasal Type
- Extranodal NK-T-Cell Lymphoma, Nasal
- Extranodal NK T Cell Lymphoma, Nasal
Below are MeSH descriptors whose meaning is more general than "Lymphoma, Extranodal NK-T-Cell".
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, Extranodal NK-T-Cell".
This graph shows the total number of publications written about "Lymphoma, Extranodal NK-T-Cell" by people in Harvard Catalyst Profiles by year, and whether "Lymphoma, Extranodal NK-T-Cell" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 4 | 0 | 4 |
| 2017 | 3 | 1 | 4 |
| 2018 | 3 | 0 | 3 |
| 2019 | 2 | 0 | 2 |
| 2020 | 2 | 0 | 2 |
| 2021 | 5 | 0 | 5 |
Below are the most recent publications written about "Lymphoma, Extranodal NK-T-Cell" by people in Profiles.
-
Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma. Blood Cancer Discov. 2022 03 01; 3(2):154-169.
-
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience. Clin Lymphoma Myeloma Leuk. 2022 05; 22(5):e300-e309.
-
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience. Clin Lymphoma Myeloma Leuk. 2022 04; 22(4):e250-e260.
-
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study. Ann Hematol. 2021 Oct; 100(10):2529-2539.
-
Mature T/NK-Cell lymphomas of the oral and maxillofacial region: A multi-institutional collaborative study. J Oral Pathol Med. 2021 Jul; 50(6):548-557.
-
Modern Radiation Therapy for Extranodal Nasal-Type NK/T-cell Lymphoma: Risk-Adapted Therapy, Target Volume, and Dose Guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2021 07 15; 110(4):1064-1081.
-
[Analysis on Clinical Characteristics and Prognosis of 47 Patients with Extranodal NK/T Cell Lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Feb; 29(1):86-90.
-
Localization patterns and survival of extranodal natural killer/T-cell lymphomas in the United States: A population-based study of 945 cases. J Am Acad Dermatol. 2021 11; 85(5):1318-1321.
-
Falling prey to a wolf in sheep's clothing: T and NK cell neoplasms with aberrant CD20 expression. Virchows Arch. 2020 12; 477(6):897-899.
-
Cardiac Lymphoma Presenting with Recurrent STEMI. Methodist Debakey Cardiovasc J. 2020 Apr-Jun; 16(2):158-161.